Fosfomycin calcium/Trimethoprim

磷霉素钙/甲氧苄啶

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFosfomycin calcium/Trimethoprim
Drug Alias NameFosfomycin Calcium and Trimethoprim Capsules磷霉素钙甲氧苄啶胶囊
ClassificationSmall molecules
Mechanisms of ActionPeptidoglycan inhibitorsCell wall inhibitorsDihydrofolate reductase inhibitors
TargetsPeptidoglycanDihydrofolate reductase
Therapy Area/IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Fosfomycin calciumTrimethoprim
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A